IP Library › Granted Patent US 8,790,682
Granted Patent B2
US 8,790,682 · App. 13/678,644 · Granted Jul 29, 2014

Devices and methods for tissue engineering

Inventors: James Jenq Liu (Mason, OH); Adam Wallen (Swampscott, MA); Juha-Pekka Nuutinen (Tampere, FI)
Assignee: Bio2 Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,790,682
App. No.
13/678,644
Granted
Jul 29, 2014
Kind
B2
Abstract

A resorbable tissue scaffold fabricated from bioactive glass fiber forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the bioactive glass fiber in the porous matrix. Strength of the bioresorbable matrix is provided by bioactive glass that fuses and bonds the bioactive glass fiber into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims (11)

1. A resorbable tissue scaffold comprising:

bioactive glass fiber bonded into a rigid three-dimensional porous matrix; and

pore space within the rigid three-dimensional porous matrix by volatile components removed during formation of the three-dimensional porous matrix,

wherein the pore space creates a porosity between about 40% and about 85% in the resorbable tissue scaffold.

2. The resorbable tissue scaffold according to claim 1 wherein the pore space within the rigid three-dimensional porous matrix has a pore size between about 100 μm and about 500 μm.

3. The resorbable tissue scaffold according to claim 2 wherein the pore size has a bi-modal size distribution.

4. The resorbable tissue scaffold according to claim 1 wherein a plurality of the bioactive glass fibers are bonded to adjacent bioactive glass fibers providing bundles of bonded bioactive glass fibers.

5. The resorbable tissue scaffold according to claim 1 wherein the bioactive glass fibers comprise sodium carbonate, calcium carbonate, phosphorus pentoxide, about 45 mol % to about 60 mol % silica, and an about 2 to an about 10 molar ratio of calcium to phosphate.

6. The resorbable tissue scaffold according to claim 1 wherein the bioactive glass fibers comprise glass fiber having a composition in respective mol % quantities of 6% Na 2 O; 7.9% K 2 O; 7.7% MgO; 22.1% CaO; 0% B 2 O 3 ; 1.7% P 2 O 5 ; and 54.6% SiO 2 .

7. The resorbable tissue scaffold according to claim 1 wherein the bioactive glass fibers have a diameter ranging from about 1 μm to about 200 μm.

8. The resorbable tissue scaffold according to claim 7 wherein the bioactive glass fibers have a diameter ranging from about 5 μm to about 100 μm.

Assignments (4)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
CHANGE OF NAME Recorded Apr 8, 2021
From: BIO2 TECHNOLOGIES, INC.
To: NOVUM MEDICAL, INC.
Reel/Frame 055872/0900 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2013
From: LIU, JAMES J.; WALLEN, ADAM; NUUTINEN, JUHA-PEKKA
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 029632/0760 →
Continuity (4)
Continuation 12832391 · Jul 8, 2010
Provisional Application 61224675 · Jul 10, 2009
Provisional Application 61234768 · Aug 18, 2009
Related Publication 20130173001A1 · Jul 4, 2013